Role of ACE inhibitors in hypertension complicated by vascular disease.
作者信息
McInnes G T
机构信息
University Department of Medicine and Therapeutics, Gardiner Institute, Western Infirmary, Glasgow.
出版信息
Br Heart J. 1994 Sep;72(3 Suppl):S33-7. doi: 10.1136/hrt.72.3_suppl.s33.
Abstract
摘要
相似文献
1
Role of ACE inhibitors in hypertension complicated by vascular disease.血管紧张素转换酶抑制剂在合并血管疾病的高血压中的作用。
Br Heart J. 1994 Sep;72(3 Suppl):S33-7. doi: 10.1136/hrt.72.3_suppl.s33.
2
Hypertension and peripheral arterial disease.高血压与外周动脉疾病。
Vasc Med. 2005 Aug;10(3):241-6. doi: 10.1191/1358863x05vm591xx.
3
4
[Physiopathology of angiotensin II and vascular lesion].[血管紧张素 II 与血管病变的病理生理学]
Clin Ter. 1997 Nov;148(11):537-41.
5
[Vascular wall renin-angiotensin system as a target of therapeutic interventions].[血管壁肾素-血管紧张素系统作为治疗干预的靶点]
Kardiologiia. 2003;43(5):82-6.
6
[Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].[动脉硬化及其并发症的药物治疗。血管紧张素转换酶抑制剂和HMG-CoA还原酶抑制剂的作用]
Schweiz Med Wochenschr. 1997 Apr 12;127(15):636-49.
7
Cardioprotection and ACE inhibitors.心脏保护作用与血管紧张素转换酶抑制剂
Clin Physiol Biochem. 1992;9(3):98-104.
8
[Angiotensin converting enzyme inhibitors for hypertension].[用于治疗高血压的血管紧张素转换酶抑制剂]
Pol Merkur Lekarski. 1997 Jan;2(7):66-70.
9
Plasma angiotensin II activity in essential hypertension. Relation with vascular complications.原发性高血压患者的血浆血管紧张素II活性。与血管并发症的关系。
Indian Heart J. 1974 Jul;26 Suppl(0):suppl:159-64.
10
[Angiotensin-converting enzyme inhibitors: recent therapeutic aspect].[血管紧张素转换酶抑制剂：近期治疗进展]
Nihon Rinsho. 1997 Aug;55(8):2067-74.
引用本文的文献
1
Angiotensin-converting enzyme inhibitors and coronary artery disease.
Cardiovasc Drugs Ther. 1996 Nov;10 Suppl 2:631-7. doi: 10.1007/BF00052510.
本文引用的文献
1
Cerebral blood flow in hypertension.高血压中的脑血流量。
Acta Med Scand Suppl. 1983;678:11-25. doi: 10.1111/j.0954-6820.1984.tb08658.x.
2
Captopril in the treatment of the elderly hypertensive patient.
Arch Intern Med. 1985 Nov;145(11):2029-31.
3
Captopril for the treatment of patients with hypertension and peripheral vascular disease.卡托普利用于治疗高血压和外周血管疾病患者。
Angiology. 1985 May;36(5):293-6. doi: 10.1177/000331978503600505.
4
Effects of captopril on the physical work capacity of normotensive patients with stable-effort angina pectoris.卡托普利对稳定型劳力性心绞痛正常血压患者体力工作能力的影响。
Cardiology. 1987;74(3):226-8. doi: 10.1159/000174201.
5
Treatment of hypertension with captopril: preservation of regional blood flow and reduced platelet aggregation.卡托普利治疗高血压：保留局部血流并减少血小板聚集。
J Hum Hypertens. 1988 Jun;2(1):21-5.
6
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.卡托普利。其药效学和药代动力学特性的最新进展，以及在高血压和充血性心力衰竭中的治疗应用。
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.
7
Placebo-controlled comparison of captopril, atenolol, labetalol, and pindolol in hypertension complicated by intermittent claudication.卡托普利、阿替洛尔、拉贝洛尔和吲哚洛尔治疗合并间歇性跛行高血压的安慰剂对照比较
Lancet. 1987 Sep 19;2(8560):650-3. doi: 10.1016/s0140-6736(87)92441-x.
8
Angiotensin-converting enzyme inhibitors. Relationship between pharmacodynamics and pharmacokinetics.血管紧张素转换酶抑制剂。药效学与药代动力学之间的关系。
Clin Pharmacokinet. 1988 Nov;15(5):295-318. doi: 10.2165/00003088-198815050-00003.
9
The variable effects of angiotensin converting enzyme inhibition on myocardial ischaemia in chronic stable angina.血管紧张素转换酶抑制对慢性稳定型心绞痛心肌缺血的可变效应。
Br Heart J. 1989 Aug;62(2):112-7. doi: 10.1136/hrt.62.2.112.
10
Comparison of enalapril and atenolol in mild to moderate hypertension.依那普利与阿替洛尔治疗轻至中度高血压的比较。
Am J Med. 1989 Apr;86(4):421-6. doi: 10.1016/0002-9343(89)90340-9.
Zotero 插件